EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study

Lorenza Magagnoli iD, Mario Cozzolino iD, Fergus J Caskey, Marie Evans iD, Claudia Torino, Gaetana Porto, Maciej Szymczak, Magdalena Krajewska, Christiane Drechsler, Peter Stenvinkel, Maria Pippias, Friedo W Dekker und 5 weitere

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfad100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Lorenza Magagnoli und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Milan, Department of Health Sciences, Milan, Italy. Hauptthemen laut MEDLINE: Chronic Kidney Disease-Mineral and Bone Disorder, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Medical Association, Stockholms Läns Landsting, Dutch Kidney Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease–mineral and bone disorder (CKD-MBD) is a common complication of CKD; it is associated with higher mortality in dialysis patients, while its impact in non-dialysis patients remains mostly unknown. We investigated the associations between parathyroid hormone (PTH), phosphate and calcium (and their interactions), and all-cause, cardiovascular (CV) and non-CV mortality in older non-dialysis patients with advanced CKD.

Methods

We used data from the European Quality study, which includes patients aged ≥65 years with estimated glomerular filtration rate ≤20 mL/min/1.73 m2 from six European countries. Sequentially adjusted Cox models were used to assess the association between baseline and time-dependent CKD-MBD biomarkers and all-cause, CV and non-CV mortality. Effect modification between biomarkers was also assessed.

Results

In 1294 patients, the prevalence of CKD-MBD at baseline was 94%. Both PTH [adjusted hazard ratio (aHR) 1.12, 95% confidence interval (CI) 1.03–1.23, P = .01] and phosphate (aHR 1.35, 95% CI 1.00–1.84, P = .05), but not calcium (aHR 1.11, 95% CI 0.57–2.17, P = .76), were associated with all-cause mortality. Calcium was not independently associated with mortality, but modified the effect of phosphate, with the highest mortality risk found in patients with both hypercalcemia and hyperphosphatemia. PTH level was associated with CV mortality, but not with non-CV mortality, whereas phosphate was associated with both CV and non-CV mortality in most models.

Conclusions

CKD-MBD is very common in older non-dialysis patients with advanced CKD. PTH and phosphate are independently associated with all-cause mortality in this population. While PTH level is only associated with CV mortality, phosphate seems to be associated with both CV and non-CV mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic Kidney Disease-Mineral and Bone DisorderRenal Insufficiency, ChronicHumansAgedCalciumParathyroid HormonePhosphatesCalcium, DietaryBiomarkersRenal Dialysis

Stichwörter der Autor:innen

CKD-MBDPTHcardiovascularmineralmortality

Substanzen

CalciumParathyroid HormonePhosphatesCalcium, DietaryBiomarkers

Autor:innen und Institutionen

  • University of Milan, Department of Health Sciences, Milan, Italy.
  • ASST Santi Paolo e Carlo, Renal Division, Milan, Italy.
  • University of Bristol, Population Health Sciences, Bristol, UK.
  • North Bristol NHS Trust, Renal Unit, Bristol, UK.
  • Karolinska Institutet, Department of Clinical Intervention and Technology (CLINTEC), Stockholm, Sweden.
  • Istituto di Fisiologia Clinica Consiglio Nazionale delle Ricerche (IFC-CNR), Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy (IT).

ORCID-Profile: Lorenza Magagnoli, Mario Cozzolino, Marie Evans, Christoph Wanner

Förderung

  • Swedish Medical Association
  • Stockholms Läns Landsting
  • Dutch Kidney Foundation
  • National Institute for Health Research

Zitieren

APA

Magagnoli, L., Cozzolino, M., Caskey, F. J., Evans, M., Torino, C., Porto, G., Szymczak, M., Krajewska, M., Drechsler, C., Stenvinkel, P., Pippias, M., Dekker, F. W., de Rooij, E. N. M., Wanner, C., Chesnaye, N. C., Jager, K. J., & EQUAL study investigators (2023). Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad100

Vancouver

Magagnoli L, Cozzolino M, Caskey FJ, Evans M, Torino C, Porto G, et al. Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfad100

BibTeX
@article{Magagnoli2023,
  author = {Magagnoli, Lorenza and Cozzolino, Mario and Caskey, Fergus J and Evans, Marie and Torino, Claudia and Porto, Gaetana and Szymczak, Maciej and Krajewska, Magdalena and Drechsler, Christiane and Stenvinkel, Peter and Pippias, Maria and Dekker, Friedo W and de Rooij, Esther N M and Wanner, Christoph and Chesnaye, Nicholas C and Jager, Kitty J and EQUAL study investigators, EQUAL study investigators},
  title = {Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfad100}
}
Kostenlos starten →